Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Geraniol Ameliorates Sepsis in Neonatal Rats by Regulating Calprotectin and Inflammatory Response

Wei Wang, YaJing Zhang, Jing Li*

Department of Emergency, Southern Campus of Guang’anmen Hospital, China Academy of Chinese Medical Sciences, No.138, Section 2, Xingfeng Street, Daxing District, Beijing, China, 102600

Abstract: Sepsis is characterized by systemic infection that causes multiple organ dysfunction and is associated with a high mortality rate in the paediatric intensive care unit. In the present study, we investigated the effect of geraniol on sepsis in neonatal rats. Sepsis was induced in neonatal rats by intraperitoneal (i.p.) inoculation with almost 6,000 colony forming units of Escherichia coli. The rats were treated with geraniol (25 or 50 mg/kg i.p.) 1 h after the administration of E. coli. Survival rate over 30 h, bacterial load, blood parameters, and inflammatory cytokines were measured. Histopathological analysis and qRT-PCR were performed on rat liver tissues. Geraniol improved the survival rate and sepsis severity in neonatal sepsis rats. Inflammatory cytokine levels, liver function test results, and blood parameters were improved in the geraniol-treated compared to sepsis group. Geraniol attenuated mRNA expression of calprotectin (S100A8/S100A9) and TLR-4 in the liver tissue of neonatal sepsis rats. Therefore, geraniol reduced bacterial load in body fluids and inflammatory mediators in neonatal sepsis rats by inhibiting calprotectin and TLR-4 pathways.

Keywords: sepsis, infection, neonatal, calprotectin, inflammation

Received September 17, 2021; Revised October 22, 2021; Accepted November 01, 2021

Citation: Wei Wang, YaJing Zhang, Jing Li, Geraniol Ameliorates Sepsis in Neonatal Rats by Regulating Calprotectin and Inflammatory Response. Journal of Food and Nutrition Research, 9 (11). 557-563. January 2021. doi:10.12691/jfnr-9-11-1

1. Introduction

Sepsis refers to a systemic inflammation or infection, and is a major cause of mortality in intensive care units worldwide [1]. The mortality rate of sepsis is higher in the neonatal age group compared to other age groups due to the weak immune response of the former [2]. Bacterial infections in adults are usually controlled by the immune system; however, the weaker immune system of neonates fails to control the infection, which may result in a severe systemic inflammatory response [3]. Despite advances in treatment, sepsis remains the leading cause of death among patients admitted to neonatal intensive care units. The management of sepsis includes supportive care and antibiotics. Inflammatory cytokines, such as interleukin (IL)-6 and tumour necrosis factor (TNF)-α, are increased in severe sepsis and contribute to the development of complications, i.e., multiple organ dysfunction [4]. Therefore, anti-inflammatory drugs are also used to treat neonatal sepsis.

The immune system is involved in the pathogenesis of sepsis, and activation of immune cells increases cytokine release [5]. Immune cells interact with pathogens to release calprotectin, which is stored in neutrophil cytoplasm [6]. Calprotectin is a biomarker of sepsis and reduced calprotectin levels are associated with attenuation of sepsis [7].

Geraniol is an acyclic monoterpenoid, which is an essential oil molecule isolated from Cymbopogon winterianus, Dracocephalum moldavica, Monarda fistulosa, and Rosa damascene [8]. Geraniol has anti-diabetic, anti-allergic, hepatoprotective, anti-inflammatory, anti-diarrheal, and antioxidant activities [9,10,11,12,13]. Geraniol regulates the immune system to produce immunomodulatory, anti-Parkinson’s, and anti-cancer effects [14,15]. In the present study, we evaluated the protective effect of geraniol against sepsis in neonatal rats.

2. Material and Methods

2.1. Animals

Mother and new-born pups were housed under controlled conditions in a pathogen-free environment. The animal experiments were approved by the Animal Ethical Committee of Southern Campus of Guang’anmen Hospital, China (IAEC/SC-GH/02/2020).

2.2. Induction of Sepsis

Sepsis was induced in neonatal rats by intraperitoneal (i.p.) inoculation with almost 6,000 colony forming units (CFU) of Escherichia coli. The neonatal rats were randomized into four groups: control (without sepsis), sepsis (vehicle treatment), geraniol 25 (treated with 25 mg/kg i.p. 1 h after sepsis induction), and geraniol 50 (treated with 50 mg/kg i.p. 1 h after sepsis induction) groups. The bacterial level was determined by quantitative blood cultures before and after 5 h of treatment. Clinical signs of sepsis were also recorded, including decreased food intake, huddling, reduced spontaneous activity, increased body temperature, and lethargy.

2.3. Percentage of survival

Neonatal rats were observed for 30 h to determine the survival rate in E. coli- and geraniol-treated rats. Appearance, Level of consciousness, Activity, Response to stimulus and eyes were recorded. Clinical signs were rated on 5-point scales (range: 0–4) with a maximum total score of 20.

2.4. Variable Score and Description

2.5. Bacterial Load

Sterile phosphate-buffered saline was injected into the peritoneum and aspirated to collect peritoneal fluid. Peritoneal fluid and blood were serially diluted. Lung and liver were isolated from the rats, homogenized, and centrifuged. The supernatant was collected and serially diluted in saline. Lung and liver tissues, peritoneal fluid, and blood were incubated on an agar plate to determine the bacterial load. Bacterial colonies were estimated as log CFU/g of tissue for organs and log CFU/mL of blood.

2.6. Biochemical Analysis and Inflammatory Cytokines

Plasma aspartate transaminase (AST) and alanine transaminase (ALT) levels (U/L) in septic rats were determined using a semi-automated analyzer. Organ tissues were homogenized and centrifuged at 4oC for 5 min at 5,000 × g. The levels of inflammatory cytokines, including IL-1β, IL-6, interferon-γ, and TNF-α, in the supernatant were estimated using ELISA (Thermo Fisher Scientific, Waltham, MA, USA).

2.7. Haematological Parameters

The Sysmex XT-2000i haematology analyser (Sysmex Corp., Kobe, Japan) was used to analyse blood parameters, including differential count, white blood cell (WBC) count, and haemoglobin level. Immunofluorescence staining was performed to estimate the CD4+/CD8+ T lymphocyte ratio using flow cytometry.

2.8. Histopathological Changes

Liver and lung tissues were fixed in 10% formalin solution and embedded in molten paraffin to prepare wax cubes. Tissues were cut into 3-μm-thick slices using a microtome and stained with hematoxylin and eosin. Histopathological changes were observed using a CX41 microscope (Olympus, Tokyo, Japan).

2.9. Determination of mRNA Expression

RNAiso Plus reagent (ThermoFisher Scientific Ltd, USA) was used to extract total RNA according to the manufacturer’s instructions. Reverse transcriptase was used to synthesize cDNA from total RNA (1 μg). The SYBR-RT PCR kit was used to perform quantitative real-time PCR (qRT-PCR). The expression levels of calprotectin (S100A8/S100A9), TLR-4, and IL-6 mRNA were estimated in tissue homogenates using qRT-PCR.

2.10. Statistical Analysis

The data are expressed as mean ± standard error of the mean (SEM; n = 8). Data were analysed by one-way analysis of variance, followed by post hoc Dunnett’s test, using GraphPad Prism software (version 6.1; GraphPad Software Inc., San Diego, CA, USA). P-values < 0.05 were considered statistically significant.

3. Results

3.1. Geraniol Improved the Survival Rate in Septic Neonatal Rats

Geraniol use significantly affected the clinical score and survival percentage of septic neonatal rats (Figure 1A & B). The percentage survival of rats was reduced by up to 10% in the sepsis compared to control group (i.e., 100%). Moreover, the percentage survival of geraniol-treated septic rats improved by up to 70% (Figure 1A). The clinical score was significantly increased (p < 0.01) by up to 20-fold in the septic compared to control group. The clinical score was significantly reduced in the geraniol-treated group compared to the sepsis group (p < 0.01) (Figure 1B).

Figure 1. Geraniol improved the survival rate in septic neonatal rats. A: Geraniol improved the survival percentage in septic neonatal rats. B: Geraniol improved the sepsis clinical severity score in neonatal rats (Mean ± SEM (n = 8); ##p < 0.01 compared to control group; *p < 0.05, **p < 0.01 compared to the sepsis group)

3.2. Geraniol Improved the Bacterial Load in Body Fluid and Tissues

The bacterial load was determined in the body tissues and fluids of geraniol-treated neonatal rats (Figure 2). The bacterial load was significantly increased in the body fluids (peritoneal fluid and blood) and tissues (liver and lung) of the septic compared to the control group (p < 0.01). However, geraniol treatment significantly reduced the bacterial load in the body fluids (peritoneal fluid and blood) and tissues (liver and lung) of septic neonatal rats.

Figure 2. Geraniol improved the bacterial load in the body fluid (peritoneal fluid and blood) and body tissues (liver and lung) of septic neonatal rats (Mean ± SEM (n = 8); ##p < 0.01 compared to the control group; *p < 0.05, **p < 0.01 compared to the sepsis group)

3.3. Geraniol Improved the Inflammatory Cytokine Levels

Figure 3 summarizes the effects of geraniol on the levels of inflammatory mediators in tissue homogenates of septic neonatal rats. The levels of inflammatory cytokines, including INF-γ, IL-1β, IL-6, and TNF-α, significantly increased in the tissue homogenates of the sepsis compared to control group. However, treatment with geraniol reduced the cytokine levels in tissue homogenates of septic neonatal rats.

Figure 3. Geraniol improved inflammatory mediators in tissue homogenates of septic neonatal rats (Mean ± SEM (n = 8); ##p < 0.01, ###p < 0.001 compared to control group; **p < 0.01, ***p < 0.001 compared to sepsis group)

3.4. Geraniol Improved Liver Function Tests

Figure 4 depicts the effects of geraniol on liver function, including plasma liver protein, in neonatal rats. Plasma AST and ALT levels were significantly increased in the plasma of the sepsis compared to control group (p < 0.001). Plasma AST and ALT levels were significantly reduced in the geraniol-treated group in a dose-dependent manner (p < 0.01; p < 0.001).

Figure 4. Geraniol improved the level of plasma liver proteins in septic neonatal rats (Mean ± SEM (n = 8); ##p < 0.01, ###p < 0.001 compared to control group; **p < 0.01, ***p < 0.001 compared to sepsis group)

3.5. Geraniol Improved Blood Parameters

The red blood cell (RBC) count, WBC count, haemoglobin, haematocrit, neutrophil and lymphocyte counts, and CD4+/CD8+ ratio were measured in the geraniol-treated septic neonatal rats. The RBC count, haematocrit, haemoglobin, and CD4+/CD8+ ratio were significantly reduced in the sepsis compared to control group (p < 0.01); these changes were attenuated by geraniol treatment in sepsis rats.

Figure 5. Geraniol improved the blood parameters of septic neonatal rats (Mean ± SEM (n = 8); ##p < 0.01 compared to control group; *p < 0.05, **p < 0.01 compared to sepsis group)

3.6. Geraniol Improved Histopathological Changes in Liver and Lung Tissues

Figure 6A & B shows the histopathological changes in lung and liver tissues of geraniol-treated septic neonatal rats revealed by hematoxylin and eosin staining. The lung and liver tissues of the control group appeared normal on histopathology. Lung tissues from the sepsis group showed histopathological changes, including pneumonitis characterized by diffuse infiltration of inflammatory cells in alveoli. Moreover, liver hepatocytes showed prominent hydropic degenerative changes in the sepsis group. However, geraniol treatment attenuated these pathological changes in the lung and liver tissues of septic neonatal rats.

Figure 6. Geraniol improved pathological changes in the liver and lung tissues of septic neonatal rats. A: Effect of geraniol on the pathological changes in the lung tissue of septic neonatal rats.; B: Effect of geraniol on the pathological changes in the liver tissue of septic neonatal rats

3.7. Geraniol Improved the mRNA Expression of Calprotectin (S100A8/S100A9), TLR-4, and IL-6

We performed qRT-PCR to determine the mRNA expression levels of S100A8, S100A9, TLR-4, and IL-6 in the liver tissues of geraniol-treated septic neonatal rats (Figure 7). The mRNA expression levels of S100A8, S100A9, TLR-4, and IL-6 were significantly increased in the liver tissue of the sepsis compared to control group (p < 0.01). The mRNA expression levels of S100A8, S100A9, TLR-4, and IL-6 were significantly reduced in the liver tissue of the geraniol-treated sepsis group.

Figure 7. Geraniol improved the mRNA expression of S100A8, S100A9, TLR-4, and IL-6 in liver tissue of septic neonatal rats (Mean ± SEM (n = 8); ##p < 0.01 compared to control group; *p < 0.05, **p < 0.01 compared to sepsis group)

4. Discussion

Sepsis is a manifestation of systemic bacterial infection characterized by immune activation. Phagocytes are activated in response to the recognition of infection by pattern recognition receptors [16]. Moreover, damage-associated molecular patterns also provide endogenous signals to activate phagocytes [17]. Inflammatory stimuli and stress stimulate the release of S100A8 and S100A9 proteins by phagocytes [18]. Adhesion molecules and pro-inflammatory cytokines are induced by S100A8 and S100A9 proteins, which have pro-inflammatory properties [19]. The levels of S100A8 and S100A9 proteins are elevated in sepsis; regulating the S100A8 and S100A9 proteins could be a potential target for the treatment of inflammation and sepsis. Therefore, we studied the effects of geraniol on the regulation of S100A8 and S100A9 proteins in sepsis.

Sepsis is a multifactorial disorder with several treatment targets, such as TLR-4 [20]. In septic shock, TLR-4 activation increases cytokine release, which exacerbates systemic inflammation and may even lead to death [21]. Liver Kupffer cells are also activated during sepsis, which causes cytokine release [22]. The significant increase in cytokines causes cellular injury, leading to multiple organ dysfunction. Our results showed that cytokine and TLR-4 expression were increased in the sepsis compared to control group, and these effects were attenuated by geraniol treatment.

Blood parameters, such as RBC, WBC, haemoglobin, haematocrit, neutrophil and lymphocyte counts, and the CD4+/CD8+ ratio, were altered in septic rats, consistent with previous studies [23]. Anaemia is a severe complication of sepsis characterized by reduced haemoglobin and haematocrit levels. Moreover, the antigenic properties of microorganisms contribute to an increase in the WBC count and decrease in the CD4+/CD8+ ratio in sepsis [24]. Sepsis is managed by correcting these blood parameters. In the current study, geraniol treatment improved the altered blood parameters.

In sepsis, histopathological changes occur in liver tissue due to injury and inflammation. Liver dysfunction in sepsis is evidenced by increased ALT and AST levels. The ALT and AST levels were significantly reduced in our geraniol-treated compared to sepsis group.

5. Conclusion

Geraniol reduced inflammatory mediators and bacterial load in body fluids in septic neonatal rats by inhibiting calprotectin and the TLR-4 pathway. Geraniol also improved blood parameters and liver function in septic neonatal rats.

Acknowledgements

The authors are thankful to the Southern Campus of Guang’anmen Hospital, China, for providing the facilities necessary to conduct the study.

References

[1]   | Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nat Rev Dis Primers. 2016 Jun 30; 2: 16045.
[2]   | Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci. 2015 Dec 22; 282(1821): 20143085.
[3]   | Minasyan, H. Sepsis: mechanisms of bacterial injury to the patient. Scand J Trauma Resusc Emerg Med. 27, 19 (2019).
[4]   | Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019 Nov 28; 20(23): 6008.
[5]   | Delano MJ, Ward PA. The immune system's role in sepsis progression, resolution, and long-term outcome. Immunol Rev. 2016 Nov; 274(1): 330-353.
[6]   | Kaplan MJ, Radic M. Neutrophil extracellular traps: double-edged swords of innate immunity. J Immunol. 2012 Sep 15; 189(6): 2689-95.
[7]   | Decembrino L, De Amici M, Pozzi M, De Silvestri A, Stronati M. Serum calprotectin: a potential biomarker for neonatal sepsis. J Immunol Res. 2015; 2015: 147973.

[8]  
Katty Anne A.L. Medeiros, José R. dos Santos, Thaís Cristina de S. Melo, Marina F. de Souza, Luciano de G. Santos, Auderlan M. de Gois, Rachel R. Cintra, Lívia Cristina R.F. Lins, Alessandra M. Ribeiro, Murilo Marchioro, Depressant effect of geraniol on the central nervous system of rats: behavior and ECoG power spectra, Biomedical Journal, Volume 41, Issue 5, 2018, Pages 298-305.

[9]   | Babukumar S, Vinothkumar V, Sankaranarayanan C, Srinivasan S. Geraniol, a natural monoterpene, ameliorates hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats. Pharm Biol. 2017 Dec; 55(1): 1442-1449.
[10]   | Xue Z, Zhang XG, Wu J, Xu WC, Li LQ, Liu F, Yu JE. Effect of treatment with geraniol on ovalbumin-induced allergic asthma in mice. Ann Allergy Asthma Immunol. 2016 Jun; 116(6): 506-13.
[11]   | Eman F. El Azab, Nihal M. Elguindy, Galila A. Yacout and Dalia A. Elgamal, 2020. Hepatoprotective impact of geraniol against ccl₄-induced liver fibrosis in rats. Pakistan Journal of Biological Sciences, 23: 1650-1658.
[12]   | Wang J, Su B, Zhu H, Chen C, Zhao G. Protective effect of geraniol inhibits inflammatory response, oxidative stress and apoptosis in traumatic injury of the spinal cord through modulation of NF-κB and p38 MAPK. Exp Ther Med. 2016 Dec; 12(6): 3607-3613.
[13]   | Rizzello, F., Ricci, C., Scandella, M. et al. Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study. BMC Complement Altern Med. 18, 338 (2018).
[14]   | Rekha KR, Inmozhi Sivakamasundari R. Geraniol protects against the protein and oxidative stress induced by rotenone in an in vitro model of Parkinson's disease. Neurochem Res. 2018 Oct; 43(10): 1947-1962.
[15]   | Cho M, So I, Chun JN, Jeon JH. The antitumor effects of geraniol: modulation of cancer hallmark pathways (Review). Int J Oncol. 2016 May; 48(5): 1772-82.
[16]   | Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009 Apr; 22(2): 240-73, Table of Contents.
[17]   | Roh JS, Sohn DH. Damage-associated molecular patterns in inflammatory diseases. Immune Netw. 2018 Aug 13; 18(4): e27.
[18]   | Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J. S100A8/A9 in Inflammation. Front Immunol. 2018 Jun 11; 9: 1298.

[19]  
Sunahori K, Yamamura M, Yamana J, Takasugi K, Kawashima M, Yamamoto H, Chazin WJ, Nakatani Y, Yui S, Makino H. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther. 2006; 8(3): R69.

[20]   | Savva A, Roger T. Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases. Front Immunol. 2013 Nov 18; 4: 387.
[21]   | Jaffer U, Wade RG, Gourlay T. Cytokines in the systemic inflammatory response syndrome: a review. HSR Proc Intensive Care Cardiovasc Anesth. 2010; 2(3): 161-75.
[22]   | Dixon LJ, Barnes M, Tang H, Pritchard MT, Nagy LE. Kupffer cells in the liver. Compr Physiol. 2013 Apr; 3(2): 785-97.
[23]   | Awoke N, Arota A. Profiles of hematological parameters in Plasmodium falciparum and Plasmodium vivax malaria patients attending Tercha General Hospital, Dawuro Zone, South Ethiopia. Infect Drug Resist. 2019 Mar 5; 12: 521-527.
[24]   | Boomer JS, Green JM, Hotchkiss RS. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer? Virulence. 2014 Jan 1; 5(1): 45-56.